Tolleson Wealth Management Inc. bought a new position in shares of Oracle Co. (NYSE:ORCL - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 2,705 shares of the enterprise software provider's stock, valued at approximately $451,000.
Several other hedge funds have also recently bought and sold shares of the business. True Wealth Design LLC increased its position in Oracle by 59.2% during the fourth quarter. True Wealth Design LLC now owns 788 shares of the enterprise software provider's stock worth $131,000 after buying an additional 293 shares during the last quarter. State of Wyoming grew its position in shares of Oracle by 406.1% in the fourth quarter. State of Wyoming now owns 6,832 shares of the enterprise software provider's stock valued at $1,138,000 after purchasing an additional 5,482 shares during the last quarter. Stonebrook Private Inc. grew its position in shares of Oracle by 27.0% in the fourth quarter. Stonebrook Private Inc. now owns 4,098 shares of the enterprise software provider's stock valued at $683,000 after purchasing an additional 871 shares during the last quarter. Strategic Wealth Partners Ltd. grew its position in shares of Oracle by 31.9% in the fourth quarter. Strategic Wealth Partners Ltd. now owns 66,481 shares of the enterprise software provider's stock valued at $11,558,000 after purchasing an additional 16,078 shares during the last quarter. Finally, Strive Asset Management LLC acquired a new stake in shares of Oracle in the fourth quarter valued at about $1,151,000. 42.44% of the stock is owned by institutional investors and hedge funds.
Oracle Stock Performance
NYSE:ORCL opened at $160.31 on Friday. Oracle Co. has a 1 year low of $114.55 and a 1 year high of $198.31. The firm has a 50 day moving average of $142.91 and a 200-day moving average of $162.49. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 5.65. The stock has a market capitalization of $448.39 billion, a P/E ratio of 39.20, a price-to-earnings-growth ratio of 3.46 and a beta of 1.27.
Oracle (NYSE:ORCL - Get Free Report) last posted its earnings results on Monday, March 10th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.49 by ($0.02). Oracle had a net margin of 21.16% and a return on equity of 133.25%. The firm had revenue of $14.13 billion during the quarter, compared to the consensus estimate of $14.40 billion. During the same quarter last year, the firm posted $1.41 EPS. The business's revenue was up 6.4% on a year-over-year basis. As a group, sell-side analysts anticipate that Oracle Co. will post 5 EPS for the current fiscal year.
Oracle Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Wednesday, April 23rd. Stockholders of record on Thursday, April 10th were paid a $0.50 dividend. The ex-dividend date was Thursday, April 10th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.25%. This is a boost from Oracle's previous quarterly dividend of $0.40. Oracle's payout ratio is 46.95%.
Wall Street Analysts Forecast Growth
Several brokerages have recently issued reports on ORCL. UBS Group reaffirmed a "market perform" rating on shares of Oracle in a research report on Tuesday, March 11th. Guggenheim reaffirmed a "buy" rating and issued a $220.00 price target on shares of Oracle in a research report on Thursday, April 3rd. StockNews.com downgraded Oracle from a "buy" rating to a "hold" rating in a research report on Wednesday, February 19th. Monness Crespi & Hardt upgraded shares of Oracle from a "sell" rating to a "neutral" rating in a research note on Monday, March 3rd. Finally, Mizuho reduced their target price on shares of Oracle from $210.00 to $180.00 and set an "outperform" rating for the company in a research note on Tuesday, April 15th. Fourteen investment analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $174.42.
Get Our Latest Stock Report on ORCL
Insider Activity
In related news, Director Leon E. Panetta sold 17,500 shares of the firm's stock in a transaction that occurred on Friday, May 2nd. The shares were sold at an average price of $151.24, for a total value of $2,646,700.00. Following the completion of the sale, the director now owns 58,090 shares of the company's stock, valued at $8,785,531.60. This trade represents a 23.15% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Naomi O. Seligman sold 2,866 shares of the firm's stock in a transaction that occurred on Monday, May 5th. The shares were sold at an average price of $149.53, for a total transaction of $428,552.98. Following the completion of the sale, the director now directly owns 31,764 shares of the company's stock, valued at approximately $4,749,670.92. This represents a 8.28% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 27,366 shares of company stock worth $4,015,723. Insiders own 42.20% of the company's stock.
Oracle Profile
(
Free Report)
Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.